Graham K. Cooper, Director at Beam Therapeutics Inc. (BEAM), sold 3,228 shares at $115.38 ($386K) on 2021-07-06, disclosed to the SEC on 2021-07-08.
Open-market sale of $386k BEAM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.38 | 614 | $71K | 18.3% |
| 2 | $115.38 | 614 | $71K | 18.3% |
| 3 | $116.41 | 200 | $23K | 6.0% |
| 4 | $118.35 | 200 | $24K | 6.1% |
| 5 | $119.68 | 100 | $12K | 3.1% |
| 6 | $120.39 | 200 |
| $24K |
| 6.2% |
| 7 | $121.59 | 400 | $49K | 12.6% |
| 8 | $122.85 | 100 | $12K | 3.2% |
| 9 | $123.76 | 200 | $25K | 6.4% |
| 10 | $124.31 | 300 | $37K | 9.7% |
| 11 | $126.51 | 100 | $13K | 3.3% |
| 12 | $128.67 | 100 | $13K | 3.3% |
| 13 | $129.38 | 100 | $13K | 3.4% |
| Total | $119.61 avg | 3,228 | $386K | 100% |
| Filing → |
| OREX | SELL | 2009-12-23 | $147K | — | Filing → |
| OREX | SELL | 2009-12-23 | $678K | — | Filing → |
| OREX | SELL | 2008-08-25 | $99K | — | Filing → |